---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-051240"
form_type: "8-K"
ticker: "IRMD"
cik: "0001325618"
company_name: "IRADIMED CORP"
filed_at: "2026-07-31T12:15:40+00:00"
generated_at: "2026-07-31T12:20:06.841365+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Iradimed Q2 revenue flat at $20.5M, EPS down; declares $0.20 dividend; reaffirms FY guidance

## Summary
- Q2 revenue $20.5M (+0.5% YoY); GAAP EPS $0.41 (down from $0.45); non-GAAP EPS $0.46 (down from $0.49).
- Declared quarterly cash dividend of $0.20 per share, payable Aug 28, 2026 to holders of record Aug 14.
- Reaffirmed FY2026 guidance: revenue $91-96M, GAAP EPS $1.90-2.05, non-GAAP EPS $2.09-2.24.
- Launched next-gen 3870 MR IV pump; initial shipments met plan; domestic monitor unit bookings set record.
- Q3 2026 guidance: revenue $23-24.5M, GAAP EPS $0.49-0.54, non-GAAP EPS $0.54-0.59.

## SEC filing metadata
- accession: 0001628280-26-051240
- form_type: 8-K
- ticker: IRMD
- cik: 0001325618
- company_name: IRADIMED CORP
- filed_at: 2026-07-31T12:15:40+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1325618/000162828026051240/0001628280-26-051240-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1325618/000162828026051240/irmd-20260731.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-051240
- JSON: https://secwatch.observer/filing/0001628280-26-051240.json
- Plain text: https://secwatch.observer/filing/0001628280-26-051240.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.